Type 2 Diabetes Trial, Recruiting (NCT07532863)

Type 2 Diabetes Trial, Recruiting NCT07532863 Sponsor: Novo Nordisk A/S Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07532863 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are aged 40 or older but under 70 years old
You can be male or female
You were newly diagnosed with type 2 diabetes and started diabetes medication between 1 January 2022 and 31 December 2023

Who may not be able to join:

You have type 1 diabetes or diabetes that developed during pregnancy (gestational diabetes)
You were taking diabetes medications before you were first diagnosed with type 2 diabetes
You are currently pregnant
You have a pre-existing heart or blood vessel condition, such as coronary heart disease, stroke, a mini-stroke (TIA), or poor circulation in the legs (peripheral artery disease)
You passed away within 12 months of your first type 2 diabetes diagnosis (confirm with trial site)
You did not have a medical appointment roughly 12 months after your first type 2 diabetes diagnosis (within a 3-month window either side)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Clinical Transparency dept. 2834, Novo Nordisk A/S

Phone: (+1) 866-867-7178

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07532863

Sponsor: Novo Nordisk A/S

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: (+1) 866-867-7178

More information: https://clinicaltrials.gov/study/NCT07532863

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are aged 40 or older but under 70 years old
You can be male or female
You were newly diagnosed with type 2 diabetes and started diabetes medication between 1 January 2022 and 31 December 2023

Who may not be able to join:

You have type 1 diabetes or diabetes that developed during pregnancy (gestational diabetes)
You were taking diabetes medications before you were first diagnosed with type 2 diabetes
You are currently pregnant
You have a pre-existing heart or blood vessel condition, such as coronary heart disease, stroke, a mini-stroke (TIA), or poor circulation in the legs (peripheral artery disease)
You passed away within 12 months of your first type 2 diabetes diagnosis (confirm with trial site)
You did not have a medical appointment roughly 12 months after your first type 2 diabetes diagnosis (within a 3-month window either side)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Novo Nordisk A/S

Registry

ClinicalTrials.gov

Start date

13 March 2026

Est. completion

1 July 2026

Where this trial is recruiting

🇮🇩 Indonesia 🇲🇾 Malaysia 🇵🇭 Philippines 🇸🇬 Singapore

Primary endpoints

Cardiometabolic profile: Systolic blood pressure at baseline; Cardiometabolic profile: Waist circumference at baseline; Cardiometabolic profile: Hip circumference at baseline; Cardiometabolic profile: Height at baseline; Cardiometabolic profile: Weight at baseline; Cardiometabolic profile: Total cholesterol at baseline; Cardiometabolic profile: High-density lipoprotein cholesterol (HDL-C) at baseline; Cardiometabolic profile: Low-density lipoprotein cholesterol (LDL-C) at baseline; Cardiometabolic profile: Non High-density lipoprotein cholesterol (Non-HDL-C) at baseline; Cardiometabolic profil...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov